Cambridge Investment Research Advisors, Inc.
Position in CUE — Cue Biopharma, Inc.
CIK 1419186
FAIRFIELD, IA
Position in CUE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$4,600
-$1,500 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.494%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 53 holders
Holding Since
Jun 2023
12 quarters on record
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $49,299,867 across 75 Biotechnology names. CUE ranks #75 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
159,749 | $6,851,634 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,055 | $4,033,157 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,832 | $3,733,396 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
284,704 | $2,183,679 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
29,059 | $2,157,921 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
37,992 | $1,807,279 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
42,754 | $1,723,413 |
All Filings in CUE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,600 | 20,000 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,100 | 20,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $14,380 | 20,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,640 | 20,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $18,220 | 20,000 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $21,800 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,140 | 20,000 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $27,528 | 22,200 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $41,958 | 22,200 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $58,608 | 22,200 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $51,060 | 22,200 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $73,000 | 20,000 | Shares | Sole | 2023-07-13 | |
| No filing history on record for this holder in this stock. | ||||||